Globus Medical Inc
GMED· NYSE
Released May 4, 2023, after the close
10-Q filed May 4, 2023, 34 days after period end · 0001562762-23-000210
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $276.69M | $230.55M | $227.34M | $174.41M |
| Net Income | $49.13M | $38.08M | $45.33M | $39.54M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.48 |
| $0.37 |
| $0.44 |
| $0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.